Effect of Escherichia coli lipopolysaccharide on Bacteroides fragilis abscess formation and mortality in mice.
To study the mechanism of synergism between Bacteroides fragilis and Escherichia coli, the effect of sublethal dose of E. coli lipopolysaccharide (LPS) (25 micrograms/mouse) was checked on B. fragilis abscess formation. LPS was administered prior or after inoculum injection. No significant difference in the abscess size was observed at necropsy on day 6. However, all the groups receiving LPS showed higher incidence of recovery of additional intestinal bacteria (23.5-45.5%) from the abscess pus. When LPS was given 4 hr prior to inoculum administration, 83-100% mortality was observed. Detailed investigation showed autoclaved cecal contents alone could also cause similar mortality. Studies with stimulation of endogenous cytokines by E. coli LPS demonstrated induction of all of them within 3 hr in the blood stream with TNF-alpha demonstrating peak at 1 hr, IL-1 alpha and IL-6 at 4 hr and IFN-gamma between 6-9 hr with moderately high levels at 4 hr. This E. coli LPS-triggered cytokine cascade possibly gets further stimulated by injection of autoclaved cecal contents containing high concentration of endotoxins (1.6 x 10(5) EU/ml) contributed by dead bacteria and lead to the mortality of animals.
Tanaka
Y
Y
Institute of Anaerobic Bacteriology, Gifu University School of Medicine, Japan.
Jotwani
R
R
Watanabe
K
K
Tanaka
K
K
Kato
N
N
Ueno
K
K
D000038:Abscess / Q000209:etiology* / Q000276:immunology; D000818:Animals; D001442:Bacteroides Infections / Q000209:etiology* / Q000276:immunology; D001441:Bacteroides fragilis / Q000472:pathogenicity; D016207:Cytokines / Q000096:biosynthesis; D004926:Escherichia coli / Q000472:pathogenicity; D008070:Lipopolysaccharides / Q000633:toxicity*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010538:Peritonitis / Q000209:etiology / Q000276:immunology
D016207:Cytokines; D008070:Lipopolysaccharides